Evaluation of Moxifloxacin ActivityIn VitroAgainstMycobacterium tuberculosis, Including Resistant and Multidrug-Resistant Strains
- 1 August 2004
- journal article
- research article
- Published by Informa UK Limited in Journal of Chemotherapy
- Vol. 16 (4), 334-336
- https://doi.org/10.1179/joc.2004.16.4.334
Abstract
The new quinolone moxifloxacin was tested against 86 strains of Mycobacterium tuberculosis including 13 resistant and 4 multiresistant strains. The antimicrobial susceptibility was tested, in parallel, using two different liquid media, the radiometric Bactec 12B and the Mycobacteria Growth Indicator Tube (Becton Dickinson, USA). All strains but two were susceptible at 0.5 microg/ml of moxifloxacin; for the remaining two strains, both multidrugresistant, the minimal inhibitory concentrations (MIC) were =2 and >4 microg/ml respectively. Our data confirm the high antitubercular in vitro activity of moxifloxacin.Keywords
This publication has 12 references indexed in Scilit:
- In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosisInternational Journal of Antimicrobial Agents, 2002
- The Continued Threat of TuberculosisEmerging Infectious Diseases, 2002
- Worldwide Incidence of Multidrug‐Resistant TuberculosisThe Journal of Infectious Diseases, 2002
- Evaluation of Automated BACTEC MGIT 960 System for Testing Susceptibility of Mycobacterium tuberculosis to Four Major Antituberculous Drugs: Comparison with the Radiometric BACTEC 460TB Method and the Agar Plate Method of ProportionJournal of Clinical Microbiology, 2002
- Activity of moxifloxacin against mycobacteriaJournal of Antimicrobial Chemotherapy, 1999
- Comparative Antimycobacterial Activity of BAY 12-8039 and GatifloxacinDrugs, 1999
- In Vitro and In Vivo Activities of Moxifloxacin and Clinafloxacin against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1998
- Activity of Clarithromycin againstMycobacterium aviumInfection in Patients with the Acquired Immune Deficiency Syndrome: A Controlled Clinical TrialAmerican Review of Respiratory Disease, 1991
- In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosisJournal of Antimicrobial Chemotherapy, 1987